WebApr 11, 2024 · HARP Stock Forecast, Price & News (Harpoon Therapeutics) S&P 500 4,109.31 DOW 33,274.15 QQQ 320.93 2 charged with cutting wires; 40,000 lose internet … WebApr 10, 2024 · Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from...
Harpoon Therapeutics Inc (HARP) Stock Price & News - Google …
WebMar 22, 2024 · On March 22, 2024, Harpoon Therapeutics, Inc., a Delaware corporation (the "Company"), entered into a Securities Purchase Agreement (the "Purchase Agreement") with the purchasers named therein (the "Purchasers"), pursuant to which the Company agreed to sell and issue shares of the Company's 8.000% Series A … WebHarpoon Therapeutics, Inc. (HARP) Stock Price, News, Quote & History - Yahoo Finance S&P 500 Dow 30 33,485.29 +2.59(+0.01%) Nasdaq +91.06(+0.76%) Russell 2000 … stickers to print at home
Harpoon Therapeutics to Participate in the Canaccord Horizons in ...
WebApr 10, 2024 · April 10, 2024 - 4:05 pm. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today announced that Julie Eastland, President and Chief Executive Officer, and Luke Walker, M.D., Chief Medical … WebFeb 24, 2024 · 92,3%. More Financials. Company. Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company. The Company is engaged in the developing a T cell … WebJan 11, 2024 · SOUTH SAN FRANCISCO, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today... stickers tourist trophy